According to a recent announcement on the National Medical Products Administration (NMPA) website, Haikou Qili Pharmaceutical has received approval for its supplemental application for the consistency evaluation of Piperacillin Sodium and Tazobactam Sodium for injection.
Researchers at the Harvard T.H. Chan School of Public Health have found that replacing animal protein with plant protein is closely associated with a lower risk of cardiovascular disease (CVD) and coronary heart disease (CHD).
